We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not a subscriber? Subscribe now for unlimited access to online articles.

Rewriting Life

Let Stem Cell Science Live!

What does it mean to respect human life?

What does it mean to respect human life? That question is at the heart of the current debate swirling around research into human embryonic stem cells, and answering it is no easy task. George W. Bush’s solution is a policy he announced in August 2001, based on the idea that each and every embryo is a life too precious to sacrifice for any cause.

But that policy, which forbids federal funding of research involving any embryonic-stem-cell line created after President Bush’s announcement, leaves some 400,000 embryos from in-vitro fertilization services (11,000 of which have already been donated for research) in frozen-storage limbo at U.S. fertility clinics.

For many advocates of stem cell research, respect for life includes a profound belief that these embryos have the potential to unlock mysteries of illness and health, and of human life itself. On this view, each unused embryo represents an opportunity to treat and even cure a host of currently intractable ailments – paralysis, Parkinson’s disease, cancer. For supporters of embryonic-stem-cell research, leaving such an opportunity on ice represents a sacrifice of something precious, and a failure to respect the lives of people suffering from such diseases.

This story is part of our September 2005 Issue
See the rest of the issue

It should come as no surprise that Technology Review favors advancing embryonic-stem-cell research. We’ve been rooting for stem cell science since 1998, when then associate editor Antonio Regalado first wrote about a small cadre of researchers struggling to isolate and cultivate embryonic stem cells. It was one of the first times that a mainstream publication had covered this emerging field, and as we worked on the piece, we wondered if the research might be too speculative to merit a cover story. We worried that publicity might endanger the field – even the researchers themselves – by drawing unwanted attention to it. But we never imagined, in the biotech-friendly Clinton years, that the biggest obstacle to embryonic-stem-cell science would be the U.S. government.

As contributing writer Charles C. Mann explains in “Braving Medicine’s Frontier,” the Bush policy was not at first blush a terribly restrictive one. But the administration’s policy turned out to be the central knot in what would become a horrific bureaucratic snarl. Four years later, U.S. stem cell researchers are still struggling to free themselves of the mess, while those in other countries, including South Korea, are pushing ahead.

When TR went to press, a majority in the U.S. Congress was trying to pass legislation that would end the restrictions Bush imposed, Bush was promising to veto the bill, and proposed alternative measures were clouding the debate. Whether or not any of these bills becomes law, it’s clearly time for legislative action that will permit U.S. stem cell science to thrive.

Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.

Subscribe today
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Print + All Access Digital.
  • Print + All Access Digital {! insider.prices.print_digital !}*

    {! insider.display.menuOptionsLabel !}

    The best of MIT Technology Review in print and online, plus unlimited access to our online archive, an ad-free web experience, discounts to MIT Technology Review events, and The Download delivered to your email in-box each weekday.

    See details+

    12-month subscription

    Unlimited access to all our daily online news and feature stories

    6 bi-monthly issues of print + digital magazine

    10% discount to MIT Technology Review events

    Access to entire PDF magazine archive dating back to 1899

    Ad-free website experience

    The Download: newsletter delivered daily

You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.